STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

SBBP STRONGBRIDGE BIO StockScouter® Report

5

StockScouter® Score

STRONGBRIDGE BIO, a micro cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral

 

Concerns

  • The multi-period measure of relative price change and consistency is well below average. Negative
  • Moving average analysis for SBBP suggests weak price movement over the medium term. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

B
N/A
C
F

Previous Ratings

5
3
4